Imexon 59643-91-3

Imexon

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

read more [+]
Systematic (IUPAC) name: 4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one
Imexon CAS number: 59643-91-3
ATC code:
PubChem: 68791
DrugBank:
Formula: C4 H5 N3 O1
Molecular mass: 111.102 g/mol
Imexon Assay/Purity: Typically NLT 98%
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.